article thumbnail

FDA releases draft guidance for Breakthrough Devices Program aimed at health inequities

Mobi Health News

When determining approval for Breakthrough Device designation, the FDA will consider whether the device addresses present health inequities.

FDA 133
article thumbnail

Public Health Product Hops

Bill of Health

On a panel together, we each presented on topics relating to product hopping, but from very different perspectives. In each scenario, public health considerations drove the product switches and the FDA actively encouraged the development of reformulated products.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

FDA takes first steps toward new guidance for adaptive medical AI

Mobi Health News

An exploratory whitepaper dropped yesterday lays out a framework that the FDA hopes to present in a future draft guidance.

FDA 111
article thumbnail

GrayMatters Health Expands FDA-Cleared PTSD Treatment Expands to US Clinics

HIT Consultant

– As the first FDA-cleared self-neuromodulation device for post-traumatic stress disorder (PTSD), Prism for PTSD™ offers a new approach to managing this debilitating condition. Broad Impact: A new analysis presented at the International Society for Traumatic Stress Studies showed significant effects across all PTSD symptom clusters.

FDA 97
article thumbnail

FDA Selects Ontada to Investigate Rare Cancers Treated in US Community Oncology Setting

HIT Consultant

Food and Drug Administration (FDA) to advance the use of real-world data (RWD) in the U.S. Study Goals & Objectives The goal of the study is to better understand how patients with rare cancers present and are treated to inform drug development for life sciences companies and the FDA. community oncology setting.

FDA 98
article thumbnail

GE HealthCare Receives FDA Clearance for Innovative Alzheimer’s Imaging Tool

HIT Consultant

Food and Drug Administration (FDA) for a groundbreaking tool in the fight against Alzheimer’s disease. This streamlined process generates quantitative results, presented in a standardized report alongside the images.

FDA 98
article thumbnail

AccurKardia’s AI-Powered ECG Software Earns FDA Breakthrough Device Designation for Aortic Stenosis Detection

HIT Consultant

Food and Drug Administration (FDA). With its initial focus on cardiology, AccurKardia provides innovative cloud-based diagnostic tools, including AccurECG™4, an FDA-cleared Class II software as a medical device (SaMD) that offers fully automated, near real-time ECG interpretation.

FDA 105